Search This Blog

Tuesday, July 30, 2019

Ironwood Pharmaceuticals EPS beats by $0.11, beats on revenue

Ironwood Pharmaceuticals (NASDAQ:IRWD): Q2 Non-GAAP EPS of $0.10 beats by $0.11; GAAP EPS of $0.08 beats by $0.15.
Revenue of $102.22M (+26.0% Y/Y) beats by $12.94M.
Shares -0.01%.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)